NCT00416143
Unknown
Phase 2
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Sudden Loss of Hearing
- Sponsor
- Sheba Medical Center
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- hearing improvement
- Last Updated
- 19 years ago
Overview
Brief Summary
sudden sensorineural hearing loss:
- idiopathic in most cases
- 5-20/100,000 new cases annually in the U.S
- no establishes pathogenesis
- treated with oral steroids in most cases
- ~50% improvement in hearing levels
- bed rest - acceptable treatment, not well investigated
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with sudden sensorineural hearing loss
Exclusion Criteria
- •age less than 16 years
- •contraindication for oral steroid treatment
- •prior steroid treatment for hearing loss
- •pregnent women
Outcomes
Primary Outcomes
hearing improvement
Study Sites (1)
Loading locations...
Similar Trials
Active, Not Recruiting
N/A
?Idiopathic sudden sensorineural hearing loss treatment by Infliximab injection (TNF-alfa blocker)? - NDEUCTR2007-004074-10-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Unknown
N/A
The SeaSHeL National Prospective Cohort StudySensory Hearing LossSensorineural Hearing LossSensorineural Hearing Loss in Left EarSensorineural Hearing Loss in Right EarSensorineural HearingNCT04108598University College, London730
Unknown
Early Phase 1
Small Sample，Unicentric，Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing LossSudden Sensorineural Hearing LossNCT05849519Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University36
Completed
Phase 2
Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing LossIdiopathic Sudden SNHLNCT05112354Assiut University40
Completed
N/A
Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing LossVestibular DisorderSudden Hearing LossNCT03951584Eye & ENT Hospital of Fudan University86